Search Results | Cancer Research | American Association for Cancer Research

1-17 of 17

Sort by

Sort Order Select

Journal Articles

IL33 Is a Key Driver of Treatment Resistance of Cancer

Chie Kudo-Saito, Takahiro Miyamoto, Hiroshi Imazeki, Hirokazu Shoji, Kazunori Aoki, Narikazu Boku

Cancer Res (2020) 80 (10): 1981–1990.

DOI: https://doi.org/10.1158/0008-5472.CAN-19-2235

Published: 15 May 2020

View article

Includes: Supplementary data

Journal Articles

Abstract 3751: A mode of treatment resistance of metastatic tumor cells: Propagation exceeds elimination in number

Chie Kudo-Saito, Yukinori Ozaki, Keiichi Kinowaki, Hidetaka Kawabata, Yamato Ogiwara

Cancer Res (2019) 79 (13_Supplement): 3751.

DOI: https://doi.org/10.1158/1538-7445.AM2019-3751

Published: 01 July 2019

View article

Journal Articles

Abstract 708: Increase of senescent mesenchymal stromal/stem cells is predictive of unresponsiveness to the treatment with immune checkpoint inhibitors

Chie Kudo-Saito, Takahiro Miyamoto, Mami Kawamura, Yamato Ogiwara, Kazunori Aoki

Cancer Res (2018) 78 (13_Supplement): 708.

DOI: https://doi.org/10.1158/1538-7445.AM2018-708

Published: 01 July 2018

View article

Journal Articles

Abstract 4701: Blocking FSTL1 ameliorates immunity against osteosarcoma

Chie Kudo-Saito, Yamato Ogiwara, Kazunori Aoki

Cancer Res (2017) 77 (13_Supplement): 4701.

DOI: https://doi.org/10.1158/1538-7445.AM2017-4701

Published: 01 July 2017

View article

Journal Articles

Abstract 3224: Blocking FSTL1 reprograms cancer-caused abnormal immunity

Chie Kudo-Saito, Masayoshi Toyoura, Yuji Shoya, Akiko Ishida, Ryoko Kon

Cancer Res (2016) 76 (14_Supplement): 3224.

DOI: https://doi.org/10.1158/1538-7445.AM2016-3224

Published: 15 July 2016

View article

Journal Articles

Abstract 250: Differential efficacy of immune checkpoint inhibitors on bone metastasis and its associated immune dysfunction

Chie Kudo-Saito, Takafumi Fuwa, Kouichi Murakami

Cancer Res (2015) 75 (15_Supplement): 250.

DOI: https://doi.org/10.1158/1538-7445.AM2015-250

Published: 01 August 2015

View article

Journal Articles

Abstract 183: Immune dysfunction cascades caused by ALCAM+ mesenchymal stem cells toward tumor progression

Chie Kudo-Saito, Takafumi Fuwa, Kouichi Murakami

Cancer Res (2014) 74 (19_Supplement): 183.

DOI: https://doi.org/10.1158/1538-7445.AM2014-183

Published: 01 October 2014

View article

Journal Articles

Induction of Immunoregulatory CD271⁺ Cells by Metastatic Tumor Cells That Express Human Endogenous Retrovirus H

Chie Kudo-Saito, Masahiro Yura, Ryusuke Yamamoto, Yutaka Kawakami

Cancer Res (2014) 74 (5): 1361–1370.

DOI: https://doi.org/10.1158/0008-5472.CAN-13-1349

Published: 02 March 2014

View article

Includes: Supplementary data

Journal Articles

Targeting FSTL1 Prevents Tumor Bone Metastasis and Consequent Immune Dysfunction

Chie Kudo-Saito, Takafumi Fuwa, Kouichi Murakami, Yutaka Kawakami

Cancer Res (2013) 73 (20): 6185–6193.

DOI: https://doi.org/10.1158/0008-5472.CAN-13-1364

Published: 14 October 2013

View article

Includes: Supplementary data

Journal Articles

Abstract 283: Cancer MET at the metastatic lesion preserves the malignant features acquired via EMT.

Chie Kudo-Saito, Yutaka Kawakami

Cancer Res (2013) 73 (8_Supplement): 283.

DOI: https://doi.org/10.1158/1538-7445.AM2013-283

Published: 15 April 2013

View article

Journal Articles

Abstract 5403: Snail+ bone-metastatic cancer cells impair CTL induction via induction of immunoregulatory MSCs

Chie Kudo-Saito, Yutaka Kawakami

Cancer Res (2012) 72 (8_Supplement): 5403.

DOI: https://doi.org/10.1158/1538-7445.AM2012-5403

Published: 15 April 2012

View article

Journal Articles

Abstract 5326: CCL2 is critical for immunoresistance in association with cancer EMT

Chie Kudo-Saito, Yutaka Kawakami

Cancer Res (2010) 70 (8_Supplement): 5326.

DOI: https://doi.org/10.1158/1538-7445.AM10-5326

Published: 15 April 2010

View article

Journal Articles

Abstract #4166: Immunoescape of cancer cells expressing an endogenous retrovirus antigen

Chie Kudo-Saito, Touru Yamamuro, Ryusuke Yamamoto, Yutaka Kawakami

Cancer Res (2009) 69 (9_Supplement): 4166.

Published: 01 May 2009

View article

Journal Articles

Immunosuppressive mechanisms induced by tumor cells during epithelial-mesenchymal transition leading to tumor metastasis

Chie Kudo-Saito, Hiromi Shirako, Yutaka Kawakami

Cancer Res (2008) 68 (9_Supplement): 2465.

Published: 01 May 2008

View article

Journal Articles

Multiple costimulatory modalities enhance CTL avidity.

Charlie T. Garnett, Mala Chakraborty, Chie Kudo-Saito, Jeffrey Schlom, James W. Hodge

Cancer Res (2006) 66 (8_Supplement): 1305.

Published: 15 April 2006

View article

Journal Articles

Induction of an antigen cascade by diversified subcutaneous/intratumoral vaccination is associated with antitumor responses

Chie Kudo-Saito, Jeffrey Schlom, James W. Hodge

Cancer Res (2005) 65 (9_Supplement): 1215–1216.

Published: 01 May 2005

View article

Journal Articles

Intratumoral vaccination and diversified subcutaneous/intratumoral vaccination with recombinant poxviruses encoding a tumor antigen and multiple costimulatory molecules.

Chie Kudo-Saito, Jeffrey Schlom, James W. Hodge

Cancer Res (2004) 64 (7_Supplement): 498.

Published: 01 April 2004

View article

NARROW

IL33 Is a Key Driver of Treatment Resistance of Cancer

Abstract 3751: A mode of treatment resistance of metastatic tumor cells: Propagation exceeds elimination in number

Abstract 708: Increase of senescent mesenchymal stromal/stem cells is predictive of unresponsiveness to the treatment with immune checkpoint inhibitors

Abstract 4701: Blocking FSTL1 ameliorates immunity against osteosarcoma

Abstract 3224: Blocking FSTL1 reprograms cancer-caused abnormal immunity

Abstract 250: Differential efficacy of immune checkpoint inhibitors on bone metastasis and its associated immune dysfunction

Abstract 183: Immune dysfunction cascades caused by ALCAM+ mesenchymal stem cells toward tumor progression

Induction of Immunoregulatory CD271⁺ Cells by Metastatic Tumor Cells That Express Human Endogenous Retrovirus H

Targeting FSTL1 Prevents Tumor Bone Metastasis and Consequent Immune Dysfunction

Abstract 283: Cancer MET at the metastatic lesion preserves the malignant features acquired via EMT.

Abstract 5403: Snail+ bone-metastatic cancer cells impair CTL induction via induction of immunoregulatory MSCs

Abstract 5326: CCL2 is critical for immunoresistance in association with cancer EMT

Abstract #4166: Immunoescape of cancer cells expressing an endogenous retrovirus antigen

Immunosuppressive mechanisms induced by tumor cells during epithelial-mesenchymal transition leading to tumor metastasis

Multiple costimulatory modalities enhance CTL avidity.

Induction of an antigen cascade by diversified subcutaneous/intratumoral vaccination is associated with antitumor responses

Intratumoral vaccination and diversified subcutaneous/intratumoral vaccination with recombinant poxviruses encoding a tumor antigen and multiple costimulatory molecules.

Email alerts

AACR Journals

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only